eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Abstracting and indexing Subscription
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
3/2010
vol. 6
 
Share:
Send email
Share:
abstract:

Review paper
Indication for percutaneous aortic valve implantation

Ibrahim Akin
,
Stephan Kische
,
Tim C. Rehders
,
Christoph A. Nienaber
,
Mathias Rauchhaus
,
Hüseyin Ince
,
Henrik Schneider
,
Andreas Liebold

Arch Med Sci 2010; 6, 3: 296-302
DOI: https://doi.org/10.5114/aoms.2010.14247
Online publish date: 2010/06/30
View full text Get citation
 
The incidence of valvular aortic stenosis has increased over the past decades due to improved life expectancy. Surgical aortic valve replacement is currently the only treatment option for severe symptomatic aortic stenosis that has been shown to improve survival. However, up to one third of patients who require lifesaving surgical aortic valve replacement are denied surgery due to high comorbidities resulting in a higher operative mortality rate. In the past such patients could only be treated with medical therapy or percutaneous aortic valvuloplasty, neither of which has been shown to improve mortality. With advances in interventional cardiology, transcatheter methods have been developed for aortic valve replacement with the goal of offering a therapeutic solution for patients who are unfit for surgical therapy. Currently there are two catheter-based treatment systems in clinical application (the Edwards SAPIEN aortic valve and the CoreValve ReValving System), utilizing either a balloon-expandable or a self-expanding stent platform, respectively.
keywords:

aortic stenosis, CoreValve, Edwards SAPIEN, EuroSCORE
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.